Furthermore, the researchers used univariate and multivariate analyses to show that FDG-PET could be used to predict survival in patients with neuroendocrine tumors. “As a rare type of cancer it ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with ...

One cancer survivor in Saratoga Springs shared how ... She was diagnosed with neuroendocrine cancer, which she said is a rare type of pancreatic cancer. Knotek said the first surgeon she saw ...

But when it came to the secondary endpoint of interim overall survival (OS), the ITM-11 cohort reached 63.4 months while the ...

Stomach (gastric) neuroendocrine cancer develops in neuroendocrine cells in the stomach ... And are trying to improve the diagnosis and treatment of stomach NETs. Survival depends on many different ...

Cabozantinib improves progression-free survival (PFS) in patients with advanced extrapancreatic neuroendocrine tumors and pancreatic neuroendocrine tumors compared with placebo. Cabozantinib ...

Lung neuroendocrine cancers are lung cancers that develop ... People cope differently with cancer and want different information. Survival depends on many factors. So no one can tell you exactly how ...

In addition to receiving my traditional cancer treatments, I also opt for integrative medicines, which have helped my mental health. The FDA will review an application for Cabometyx as a potential ...